Immune and Histopathological Biomarkers for Prognosis and Neoadjuvant Immunotherapy Response in Intrahepatic Cholangiocarcinoma.

Liver Cancer · 2026 · PMC12503705 · PMID 41063739

Europe PMC DOI

hedged sentences

0.1920

closest p · 3.8× alpha

0.1920

boldest claim

The sentences

did not reach statistical significancep = 0.192not close (p > 0.1)

4 b; HR = 0.306; p = 0.037), although its association with DFS did not reach statistical significance (HR = 0.681; p = 0.192).

also in 111,027 other papers

showed a trendno p-value reported

8A) showed a trend toward improved survival in iCCA patients (online suppl.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.